Back

Characterization of Liver Metastasis Risk and Timing in Pancreatic Cancer Patients Using Electronic Health Records

talukdar, n.; Yu, Z.; Zeng, Z.; Zhang, X.; Lu, Y.; Joseph, D. F.; Leshchiner, D.; Wang, H.; Chen, B.

2025-11-02 oncology
10.1101/2025.10.31.25339268 medRxiv
Show abstract

BackgroundLiver metastasis is a frequent and serious complication of pancreatic cancer, contributing to its high mortality rate. Identifying risk factors and understanding the timing of liver metastasis may improve early detection and support more effective treatment planning. MethodA cohort of 12,955 incident pancreatic cancer patients was assembled from the Truveta platform. A subgroup of cases and controls that met the inclusion/exclusion criteria was analyzed using logistic regression and was reported as the primary analysis for this study. Effects on time to liver metastasis were also analyzed using univariate and multivariate Cox regression models. The primary outcome was the occurrence of liver metastasis within 1 year of diagnosis. Subjects were categorized as having baseline metastasis ([≤] 30 days from pancreatic cancer diagnosis) or post-baseline metastasis (>30 days). Demographic characteristics and comorbidities were evaluated for their potential role as risk factors. ResultAmong 7,858 patients in the case-control cohort, 2,920 (37%) developed liver metastasis within one year, while 2,066 (70%) subjects were diagnosed with metastasis at baseline. Male sex, older age, and a history of Type 2 diabetes mellitus, depression, obesity, anemia, abdominal pain, and distant metastasis were significantly associated with a higher risk of liver metastasis. Lower odds of liver metastasis were observed among Black or African American and Hispanic or Latino subjects. In the subgroup analysis after removing baseline metastasis, surgery and radiotherapy were protective, while tumors located in the head of the pancreas showed a higher risk for metastasis in this cohort. ConclusionsThis study identified key clinical and demographic risk factors for liver metastasis in pancreatic cancer, emphasizing the importance of using real-world data, analyzing the timing of disease progression, and highlighting opportunities for earlier intervention and personalized care.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cancer Medicine
24 papers in training set
Top 0.1%
17.3%
2
BMC Cancer
52 papers in training set
Top 0.1%
12.5%
3
Frontiers in Oncology
95 papers in training set
Top 0.3%
8.3%
4
PLOS ONE
4510 papers in training set
Top 29%
6.2%
5
Scientific Reports
3102 papers in training set
Top 25%
4.8%
6
PeerJ
261 papers in training set
Top 1%
4.8%
50% of probability mass above
7
British Journal of Cancer
42 papers in training set
Top 0.3%
4.3%
8
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.1%
4.1%
9
Cancers
200 papers in training set
Top 1%
3.9%
10
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
2.7%
11
International Journal of Cancer
42 papers in training set
Top 0.4%
2.3%
12
JAMA Network Open
127 papers in training set
Top 2%
1.9%
13
BMJ Open
554 papers in training set
Top 8%
1.9%
14
Gastroenterology
40 papers in training set
Top 1%
1.7%
15
Annals of Oncology
13 papers in training set
Top 0.6%
1.5%
16
Cancer Letters
32 papers in training set
Top 0.3%
1.5%
17
JMIR Research Protocols
18 papers in training set
Top 0.8%
1.5%
18
Hepatology Communications
21 papers in training set
Top 0.3%
1.3%
19
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.3%
20
eLife
5422 papers in training set
Top 51%
1.1%
21
Cureus
67 papers in training set
Top 4%
0.9%
22
International Journal of Environmental Research and Public Health
124 papers in training set
Top 6%
0.9%
23
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.6%
0.8%
24
EClinicalMedicine
21 papers in training set
Top 0.9%
0.8%
25
Gut
36 papers in training set
Top 1%
0.6%
26
JCO Precision Oncology
14 papers in training set
Top 0.5%
0.6%